DeepDTF: Dual-Branch Transformer Fusion for Multi-Omics Anticancer Drug Response Prediction
DeepDTF: Dual-Branch Transformer Fusion for Multi-Omics Anticancer Drug Response Prediction explores A dual-branch Transformer fusion framework predicts anticancer drug response from multi-omics data, outperforming baselines and providing biological explanations.. Commercial viability score: 7/10 in Medical AI.
Updated 2 days ago
BUILDER'S SANDBOX
Build This Paper
Use an AI coding agent to implement this research.
OpenAI CodexAI Agent
Lightweight coding agent in your terminal.
Claude CodeAI Agent
Agentic coding tool for terminal workflows.
AntiGravity IDEScaffolding
AI agent mindset installer and workflow scaffolder.
CursorIDE
AI-first code editor built on VS Code.
VS CodeIDE
Free, open-source editor by Microsoft.
Recommended Stack
Startup Essentials
Estimated $9K - $13K over 6-10 weeks.
See exactly what it costs to build this -- with 3 comparable funded startups.
7-day free trial. Cancel anytime.
Discover the researchers behind this paper and find similar experts.
7-day free trial. Cancel anytime.
Related Papers
- Builds On ThisBioCOMPASS: Integrating Biomarkers into Transformer-Based Immunotherapy Response PredictionViability: 6.0
- Prior WorkLaPro-DTA: Latent Dual-View Drug Representations and Salient Protein Feature Extraction for Generalizable Drug--Target Affinity PredictionViability: 7.0
- Higher ViabilityDPD-Cancer: Explainable Graph-based Deep Learning for Small Molecule Anti-Cancer Activity PredictionViability: 8.0
- Higher ViabilityDeepHistoViT: An Interpretable Vision Transformer Framework for Histopathological Cancer ClassificationViability: 8.0